{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:26:33Z","timestamp":1759422393320,"version":"3.41.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"DOI":"10.7759\/cureus.86644","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T09:36:02Z","timestamp":1750757762000},"source":"Crossref","is-referenced-by-count":1,"title":["A Royal Flush: Carcinoid Heart Disease Complicated by Severe Tricuspid and Pulmonic Valve Regurgitation"],"prefix":"10.7759","author":[{"given":"Syed Rafay H","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Appareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallacy","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Vashistha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny K","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Mahfooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derar","family":"Albashaireh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar J","year":"2017","unstructured":"Davar J, Connolly HM, Caplin ME, et al.. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017, 69:1288-304. 10.1016\/j.jacc.2016.12.030","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000225948","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers","volume":"90","author":"O'Toole D","year":"2009","unstructured":"O'Toole D, Grossman A, Gross D, et al.. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers. Neuroendocrinology. 2009, 90:194-202. 10.1159\/000225948","journal-title":"Neuroendocrinology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.04.012","article-title":"Carcinoid heart disease: a review","volume":"47","author":"Hayes AR","year":"2018","unstructured":"Hayes AR, Davar J, Caplin ME. Carcinoid heart disease: a review. Endocrinol Metab Clin North Am. 2018, 47:671-82. 10.1016\/j.ecl.2018.04.012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021, 77:450-500. 10.1016\/j.jacc.2020.11.035","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Nishimura RA","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al.. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017, 135:e1159-95. 10.1161\/CIR.0000000000000503","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01529","article-title":"Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline","volume":"41","author":"Del Rivero J","year":"2023","unstructured":"Del Rivero J, Perez K, Kennedy EB, et al.. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. J Clin Oncol. 2023, 41:5049-67. 10.1200\/JCO.23.01529","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381033-a-royal-flush-carcinoid-heart-disease-complicated-by-severe-tricuspid-and-pulmonic-valve-regurgitation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T09:36:03Z","timestamp":1750757763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381033-a-royal-flush-carcinoid-heart-disease-complicated-by-severe-tricuspid-and-pulmonic-valve-regurgitation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.86644","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}